Trial
NCT04458259
Study of PF-07265807 in Participants With Metastatic Solid Tumors.
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Neoplasm Metastasis
Intervention
PF-07265807
Why stopped
Pfizer has made an internal business decision to not continue further development of PF-07265807. This decision was not due to major safety concerns or requests from any regulatory authorities.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04